Marqeta (MQ) is back in focus after its fourth quarter 2025 update, which paired higher reported sales and a sharply smaller net loss with fresh 2026 guidance on revenue and gross profit growth.
See our latest analysis for Marqeta.
Marqeta’s earnings update and 2026 guidance have arrived after a softer patch in the stock. The 7 day share price return of 4.88% contrasts with a 90 day share price return of negative 15.35% and a 3 year total shareholder return of negative 3.09%. This suggests short term momentum is picking up while longer term performance remains subdued around the latest share price of US$4.08.
If Marqeta’s results have you looking across the payments and fintech space, this could be a good moment to scan a broader set of fintech enablers through our list of 60 profitable AI stocks that aren't just burning cash.
With Marqeta guiding for double digit revenue and gross profit growth in 2026 and the shares trading at US$4.08 after a weaker 90 day stretch, is this an underappreciated fintech enabler, or is the market already pricing in that outlook?
Most Popular Narrative: 28.8% Undervalued
With Marqeta’s last close at US$4.08 and the most followed narrative implying fair value at about US$5.73, the valuation debate centers on how durable its growth and margin outlook really is.
The completed TransactPay acquisition gives Marqeta full program management and EMI capabilities in Europe, enabling entry into larger enterprise opportunities, uniformity of service across North America and Europe, and easier multi-market expansion for clients. This unlocks new revenue streams, increases take rates, and improves earnings scalability.
Curious what kind of revenue path and margin profile could support that fair value, along with the profit multiple implied for a still unprofitable issuer processor? The narrative leans heavily on steady top line expansion, improving profitability and a rich earnings multiple years out, all tied together under a single discount rate.
Result: Fair Value of $5.73 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, this hinges on a few pressure points, particularly Marqeta’s reliance on major clients and the risk that intensifying competition compresses pricing and margins over time.
Find out about the key risks to this Marqeta narrative.
Another Take: Sales Multiple Sends A Different Signal
Those fair value narratives around US$5.73 suggest upside, but the current P/S of 2.8x tells a tougher story. It sits above the US Diversified Financial industry at 2.3x and the peer average at 1.7x, and even above the fair ratio of 2.2x, which hints at valuation risk if expectations reset.
See what the numbers say about this price in more detail, and how it stacks up against similar names, by checking out our valuation breakdown, See what the numbers say about this price — find out in our valuation breakdown. before you decide where Marqeta sits in your watchlist.
Next Steps
If this mix of optimism and concern feels familiar, it may be a good time to look at the numbers yourself, weigh the trade offs, and consider what you think about the company’s 1 key reward and 1 important warning sign.
Looking for more investment ideas?
If Marqeta has sharpened your focus on where you put your money next, do not stop here, the wider market holds plenty of compelling alternatives worth your attention.
- Target stability first by scanning companies in our 63 resilient stocks with low risk scores. This helps you focus on businesses with lower risk scores instead of reacting to every market swing.
- Seek quality at a sensible price by checking our 46 high quality undervalued stocks, where you can sort through companies that pair solid fundamentals with valuations that may leave room for upside.
- Build a resilient core by reviewing income focused opportunities in the 14 dividend fortresses, especially if you want potential cash returns that can complement any growth exposures in your portfolio.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com